Institute Of Hematology & Blood Diseases Hospital, China

This study was designed to test a drug called CM-336 in people with AL amyloidosis whose disease came back or didn't get better enough after initial treatment. The drug works by helping the immune system attack harmful cells. The trial was withdrawn before enrolling any participa…

This study tests a new treatment for people with a type of blood cancer called B-cell non-Hodgkin lymphoma that has come back or not responded to standard therapy. The treatment combines two advanced immune therapies: a bispecific antibody and CAR-T cells. The goal is to see if t…

This study looks at 500 male patients with severe hemophilia A or B in China to understand the disease's impact on their lives and the costs of care. Researchers will collect information from patients and doctors to see how treatment varies across different regions and hospitals.…